Log in
Login
Password
Remember
Lost password
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Xetra  >  Merck KGaA    MRK   DE0006599905

 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Xetra
02/01/2016 02/02/2016 02/03/2016 02/04/2016 02/05/2016 Date
80.41(c) 80.12(c) 77.82(c) 76.08(c) 75.69(c) Last
349 780 410 273 393 845 439 954 583 159 Volume
+0.41% -0.36% -2.87% -2.24% -0.51% Change
More quotes
Financials (€)
Sales 2015 12 861 M
EBIT 2015 2 942 M
Net income 2015 1 347 M
Debt 2015 13 080 M
Yield 2015 1,42%
Sales 2016 15 313 M
EBIT 2016 3 314 M
Net income 2016 1 682 M
Debt 2016 11 197 M
Yield 2016 1,65%
P/E ratio 2015 25,95
P/E ratio 2016 19,50
EV / Sales 2015 1,78x
EV / Sales 2016 1,37x
Capitalization 9 782 M
More Financials
Company
Merck KGaA engages in the manufacturing of pharmaceutical and chemical products.The company operates through following divisions: Healthcare, Performance Materials and Life Science, which comprise the Groups six businesses.The Healthcare division is sub divided into Biopharmaceuticals and Consumer... 
Sector
Pharmaceuticals
Calendar
03/08Earnings Release
More about the company
Surperformance© ratings of Merck KGaA
Trading Rating : Investor Rating :
More Ratings
Latest news on MERCK KGAA
02/04 MERCK KGAA : Studies from Merck KGaA Describe New Findings in Genetics (Impact o..
02/03 MERCK KGAA : Set to Launch New Version of Fertility Pens
01/28 MERCK KGAA : EMD Serono has a new chief, one month after previous presidents dep..
01/28 MERCK KGAA : Accelerator goes global with launch in Africa
01/27 MERCK KGAA : Reports from Merck KGaA Highlight Recent Findings in Xenobiotics (T..
01/27 MERCK KGAA : Researchers from Merck KGaA Report Findings in Immunoglobulins (S-S..
01/27 MERCK KGAA : EMD Serono Takes on Exclusive Promotion of Rebif® interferon beta-1..
01/27 MERCK KGAA : Announces New Biopharma Heads for North America and China
More news
Sector news : Specialty & Advanced Pharmaceuticals
02/05 SANOFI : Muzammil Mansuri is Sanofi’s new Executive Committee member
02/05 SANOFI : Zealand clarifies its role in US patent litigation relating to lixisena..
02/05 H LUNDBECK A/S : FDA Psychopharmacologic Drug Advisory Committee supports the ef..
More sector news : Specialty & Advanced Pharmaceuticals
4-Traders Strategies on MERCK KGAA 
2014Prices move higher as positive news are released
2014A gap-filling is anticipated
More Strategies
News from SeekingAlpha
01/11 Merck KGaA returns rights to evofosfamide to Threshold Pharma
01/04 Merck KGaA, Pfizer and Syndax to evaluate avelumab/entinostat combo in ovaria..
2015 Pfizer and Germany's Merck initiate two late-stage studies of avelumab in ova..
2015 Pfizer and Merck KGaA commence late-stage trials of avelumab in gastric cance..
2015 Threshold's lead product candidate flunks two late-stage trials; shares plumm..


Comments 
Advertisement
Chart MERCK KGAA
Duration : Period :
Merck KGaA Technical Analysis Chart | MRK | DE0006599905 | 4-Traders
Full-screen chart
Technical analysis trends MERCK KGAA
Short TermMid-TermLong Term
TrendsBearishNeutralBearish
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions